He was previously released from federal custody in May 2022 after being sentenced and serving 70 months in prison.

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

LONDON - The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for ...

More than a billion people now have obesity worldwide, according to the WHO, and around 70% of them live in low and middle-income countries, the World Bank estimates. The drugs have been launched ...

The Indian drug regulator Central Drugs Standard Control Organization (CDSCO) has flagged a wide range of medicines from eye ...

What does justice look like when we reflect on the harms caused to Black men and their communities through unethical research ...

Seven suspects are in custody following a sweeping law enforcement operation that dismantled a drug trafficking organization ...

RENO, Nev. (KOLO) - A 70-year-old man has been found guilty of trafficking more than a pound of meth and four grams of ...

One of the UK's largest prisons is failing to tackle an "alarming" amount of drugs that have led to a "spate" of deaths, a ...

GLP-1 drugs include Ozempic and Rybelsus ... and tirzepatide (Mounjaro) products made up 70 percent of all U.S. GLP-1 spending. Also in 2023, products that were approved to treat Type 2 diabetes ...

A police raid on a Derbyshire property saw officers seize cash, a weapon and a “large quantity of suspected Class A drugs” – ...